Division of Nephrology, Hypertension and Kidney Transplantation, University of California Irvine, Orange, CA, USA; Tibor Rubin Veterans Affairs Medical Center, Long Beach, CA, USA.
Duke-NUS Graduate Medical School, Singapore; Department of Renal Medicine, Singapore General Hospital, Singapore; Duke Global Health Institute, Durham, NC, USA.
Lancet. 2021 Aug 28;398(10302):786-802. doi: 10.1016/S0140-6736(21)00519-5. Epub 2021 Jun 24.
Chronic kidney disease is a progressive disease with no cure and high morbidity and mortality that occurs commonly in the general adult population, especially in people with diabetes and hypertension. Preservation of kidney function can improve outcomes and can be achieved through non-pharmacological strategies (eg, dietary and lifestyle adjustments) and chronic kidney disease-targeted and kidney disease-specific pharmacological interventions. A plant-dominant, low-protein, and low-salt diet might help to mitigate glomerular hyperfiltration and preserve renal function for longer, possibly while also leading to favourable alterations in acid-base homoeostasis and in the gut microbiome. Pharmacotherapies that alter intrarenal haemodynamics (eg, renin-angiotensin-aldosterone pathway modulators and SGLT2 [SLC5A2] inhibitors) can preserve kidney function by reducing intraglomerular pressure independently of blood pressure and glucose control, whereas other novel agents (eg, non-steroidal mineralocorticoid receptor antagonists) might protect the kidney through anti-inflammatory or antifibrotic mechanisms. Some glomerular and cystic kidney diseases might benefit from disease-specific therapies. Managing chronic kidney disease-associated cardiovascular risk, minimising the risk of infection, and preventing acute kidney injury are crucial interventions for these patients, given the high burden of complications, associated morbidity and mortality, and the role of non-conventional risk factors in chronic kidney disease. When renal replacement therapy becomes inevitable, an incremental transition to dialysis can be considered and has been proposed to possibly preserve residual kidney function longer. There are similarities and distinctions between kidney-preserving care and supportive care. Additional studies of dietary and pharmacological interventions and development of innovative strategies are necessary to ensure optimal kidney-preserving care and to achieve greater longevity and better health-related quality of life for these patients.
慢性肾脏病是一种进行性疾病,无法治愈,发病率和死亡率高,常见于普通成年人群,尤其是糖尿病和高血压患者。保护肾功能可以改善预后,可以通过非药物策略(如饮食和生活方式调整)和针对慢性肾脏病和肾脏病特异性的药物干预来实现。植物性为主、低蛋白、低盐饮食可能有助于减轻肾小球高滤过,更长时间地保护肾功能,同时可能导致酸碱平衡和肠道微生物组的有利改变。改变肾内血液动力学的药物治疗(如肾素-血管紧张素-醛固酮系统调节剂和 SGLT2[SLC5A2]抑制剂)可以通过独立于血压和血糖控制降低肾小球内压来保护肾功能,而其他新型药物(如非甾体类盐皮质激素受体拮抗剂)可能通过抗炎或抗纤维化机制来保护肾脏。一些肾小球和囊性肾病可能受益于特定疾病的治疗。对于这些患者,管理慢性肾脏病相关心血管风险、最大限度降低感染风险和预防急性肾损伤是至关重要的干预措施,因为并发症负担高、相关发病率和死亡率高,以及非传统危险因素在慢性肾脏病中的作用。当需要进行肾脏替代治疗时,可以考虑逐步过渡到透析,这可能有助于更长时间地保留残余肾功能。保留肾脏的治疗和支持性治疗之间存在相似之处和区别。需要进一步研究饮食和药物干预措施,并开发创新策略,以确保提供最佳的保留肾脏的治疗,并为这些患者实现更长的寿命和更好的健康相关生活质量。
Lancet. 2021-8-28
Expert Rev Clin Pharmacol. 2018-12-3
Am J Physiol Renal Physiol. 2021-4-1
Lancet Diabetes Endocrinol. 2018-12-19
Semin Nephrol. 2014-5
Am J Nephrol. 2019-10-18
Diabetes Care. 2016-8
PLoS One. 2025-9-5
Hepatobiliary Surg Nutr. 2025-8-1
Am J Cardiovasc Drugs. 2025-8-25